Original articleArginylation regulates myofibrils to maintain heart function and prevent dilated cardiomyopathy
Highlights
► New role of posttranslational arginylation in the heart muscle. ► New regulatory mechanism of myofibril maintenance and contractility. ► New insights into posttranslational regulation of the sarcomeric proteins. ► New correlation between cardiac myofibril forces, heart defects, and arginylation.
Introduction
Protein arginylation is a poorly understood posttranslational modification mediated by arginyltransferase ATE1 [1], which transfers arginine (Arg) from arginyl-tRNA onto proteins [2], [3], [4], [5], [6]. While Ate1 preferentially transfers Arg to amino acid residues with acidic side chains (Wang et al., 2011), a large number of proteins arginylated in vivo on different sites have been identified [7], [8]. The chemistry of the arginylation reaction, as well as its downstream effects on the majority of protein targets, are not well understood.
In yeast, Ate1 gene is not essential for cell viability, but Ate1 knockout in mice results in embryonic lethality between embryonic days E12.5 and E17.5 and severe defects in cardiovascular development and angiogenesis [9]. Among these defects, especially prominent are severe abnormalities in cardiac morphogenesis, including thin myocardium, underdeveloped septa, and non-separation of the aorta and pulmonary artery (persistent truncus arteriosus, PTA) [9]. Analysis of the heart muscle and cardiomyocytes isolated from Ate1 knockout embryos at E12.5–E14.5 reveals defects in cardiac contractility, heart integrity, and myofibril development [10], including myofibril disorganization, sarcomere collapse, and disintegration of the intercalated disks that become more prominent at later developmental stages (E14.5 and on). However it is not clear whether any of these defects are cell-autonomous or whether they arise through impairments in tissue signaling and/or are secondary to the onset of the embryonic lethality, leading to the heart muscle disintegration as the animals die.
To address these questions and test the specific role of arginylation in cardiomyocytes during heart development and postnatal function, we generated cardiac muscle-specific Ate1 knockout mice, in which Ate1 deletion via Cre-mediated recombination is driven by cardiomyocyte-specific alpha myosin heavy chain (αMHC) promoter [11]. These mice, termed αMHC-Ate1, survived to adulthood, but developed age-related dilated cardiomyopathy and thrombosis, accompanied by early myofibril defects and resulting in high rates of lethality after 6 month of age. Our results demonstrate a cell-autonomous role of arginylation in cardiomyocytes, where it is essential for the maintenance of the normal heart function and prevention of cardiomyopathy and heart failure. Our study also provides a mouse model of age-related heart failure with symptoms reminiscent of human heart disease, which has a potentially broad outreach in developing novel heart disease therapeutics.
Section snippets
Transgenic mice
To obtain αMHC-Ate1 mice, Ate1-floxed mice [12], [13] were crossed with the mouse strain expressing Cre recombinase under αMHC promoter [11]. For the reporter analysis shown in Fig. S1, αMHC-Ate1 mice were crossed to R26R ROSA reporter strain and fixed embryos were stained with X-gal as described in [12].
Anatomical and histological analysis
For anatomical examination, mice found dead or euthanized were dissected to assess the morphology of the chest cavity (for fluid accumulation) and the hearts. To determine heart:body weight
Generation of αMHC-Ate1 mice
To develop a mouse model with cardiomyocyte specific Ate1 knockout, we used our previously developed ‘Ate1-floxed’ mouse line [12], [13] and crossed it with αMHC-Cre mice [11], in which Cre recombinase is expressed under cardiomyocyte-specific α-myosin heavy chain promoter that activates upon differentiation, resulting in Ate1 deletion in the heart muscle. These mice, termed αMHC-Ate1 mice, were used in the present study. To confirm the efficiency and specificity of the Cre transgene
Discussion
Our results demonstrate a cell-autonomous role of arginylation in the development and function of the heart muscle, and identify arginylation as a novel mechanism that maintains cardiac health and prevents the development of dilated cardiomyopathy in mice (Fig. 5). It has been previously shown that arginylation is essential for cardiac morphogenesis and the development of heart muscle in embryogenesis [9], [10], however only the use of the current αMHC-Ate1 mouse model made it possible to
Disclosure statement
There are no conflicts of interest to disclose.
The following are the supplementary related to this article.
Acknowledgments
We thank Dr. Catherine Wong for help with manual validation of arginylated protein mass spectra and Dr. Susan Shultz (University of Pennsylvania Small Animal Imaging Facility) for performing mouse echocardiography. This work was supported by NIH R01 HL084419, W.W. Smith Charitable Trust, and Philip Morris Research Management Group awards to A.K. and NIH P41 RR011823 and N01-HV-00243 awards to J.R.Y.
References (33)
- et al.
Cloning and functional analysis of the arginyl-tRNA-protein transferase gene ATE1 of Saccharomyces cerevisiae
J Biol Chem
(1990) - et al.
A soluble amino acid incorporating system
Biochem Biophys Res Commun
(1963) The arginine transfer reaction
Biochim Biophys Acta
(1968)- et al.
A soluble amino acid-incorporating system from rat liver
Biochim Biophys Acta
(1963) - et al.
Calcium binding kinetics of troponin C strongly modulate cooperative activation and tension kinetics in cardiac muscle
J Mol Cell Cardiol
(2011) - et al.
Arginyltransferase is an ATP-independent self-regulating enzyme that forms distinct functional complexes in vivo
Chem Biol
(2011) - et al.
Arginylation and methylation double up to regulate nuclear proteins and nuclear architecture in vivo
Chem Biol
(2011) - et al.
Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2 + fluxes
J Mol Cell Cardiol
(2010) - et al.
Molecular mechanisms of sarcomere dysfunction in dilated and hypertrophic cardiomyopathy
Prog Pediatr Cardiol
(2011) - et al.
Mutations in troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?
J Mol Cell Cardiol
(2010)
Arginyl-tRNA-protein transferase activities in crude supernatants of rat tissues
Biol Pharm Bull
Further studies on the soluble amino acid incorporating system from rat liver
Biochemistry
Global analysis of posttranslational protein arginylation
PLoS Biol
Identification of N-terminally arginylated proteins and peptides by mass spectrometry
Nat Protoc
An essential role of N-terminal arginylation in cardiovascular development
Science
Arginyltransferase regulates alpha cardiac actin function, myofibril formation and contractility during heart development
Development
Cited by (38)
Regulation of actin isoforms in cellular and developmental processes
2020, Seminars in Cell and Developmental BiologyAnalyzing N-terminal arginylation through the use of peptide arrays and degradation assays
2016, Journal of Biological ChemistryCitation Excerpt :To the best of our knowledge, none of the MS-based evidence about significant levels of protein arginylation either at non-canonical N-terminal residues or at specific internal residues (87–92, 94–96) has been examined, thus far, using independent, non-MS methods. We addressed the possibility of non-canonical arginylation by asking, using C-terminally immobilized 11-residue CelluSpots peptides and [14C]arginylation assays, whether specific amino acid sequences that encompass the previously reported non-canonical arginylation sites (87–92, 94–96) are capable of being significantly arginylated by the purified Ate1 R-transferase. One set of [14C]arginylation assays was carried out with the peptide ALYENKPRRPY and its derivatives at position 4.
Two Kinases to Soften the Heart
2016, Biophysical JournalIron-sulfur clusters are involved in post-translational arginylation
2023, Nature CommunicationsCardiac-Specific Expression of Cre Recombinase Leads to Age-Related Cardiac Dysfunction Associated with Tumor-like Growth of Atrial Cardiomyocyte and Ventricular Fibrosis and Ferroptosis
2023, International Journal of Molecular Sciences
- 1
Present address: University of Hiroshima, Hiroshima, Japan.
- 2
Present address: Tezpur University, Napaam, India.